Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trialsInterleukin-6 억제제는 코로나바이러스 질병-2019의 사망률을 감소시킵니다: 무작위 대조 시험의 개별 환자 데이터 메타 분석Meta-Analysis Published on 2022-07-012022-09-11 Journal: European journal of internal medicine [Category] [DOI] 10.1016/j.ejim.2022.04.004 PMC 바로가기 [Article Type] Meta-Analysis
Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort studyResearch article Published on 2022-07-012022-10-05 Journal: The Lancet Regional Health - Americas [Category] [DOI] 10.1016/j.lana.2022.100228 [Article Type] Research article
Glucocorticoids Bind to SARS-CoV-2 S1 at Multiple Sites Causing Cooperative Inhibition of SARS-CoV-2 S1 Interaction With ACE2글루코코르티코이드는 여러 부위에서 SARS-CoV-2 S1에 결합하여 ACE2와 SARS-CoV-2 S1 상호작용을 협력적으로 억제합니다Article Published on 2022-06-152022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.906687 PMC 바로가기 [Article Type] Article
Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trialsResearch article Published on 2022-06-032022-10-05 Journal: EClinicalMedicine [Category] [DOI] 10.1016/j.eclinm.2022.101489 [Article Type] Research article
A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19시스템 생물학 접근 방식으로 COVID-19 중증 환자의 사망률을 줄이기 위한 후보 약물 식별Article Published on 2022-06-032022-09-11 Journal: Science Advances [Category] [DOI] 10.1126/sciadv.abm2510 PMC 바로가기 [Article Type] Article
Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomesCOVID-19 심각한 결과의 잠재적인 예측자로서 염증의 순환 바이오마커Review Published on 2022-06-012022-09-11 Journal: Mechanisms of ageing and development [Category] [DOI] 10.1016/j.mad.2022.111667 PMC 바로가기 [Article Type] Review
Does melatonin reduce mortality in COVID-19?Correspondence Published on 2022-06-012022-10-05 Journal: Annals of Medicine and Surgery [Category] [DOI] 10.1016/j.amsu.2022.103817 [Article Type] Correspondence
Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID-19 patients: A meta-analysisCOVID-19 환자에서 염증성 바이오마커 감소에 대한 아나킨라 치료 효능: 메타 분석Meta-Analysis Published on 2022-06-012022-09-11 Journal: Journal of Clinical Laboratory Analysis [Category] [DOI] 10.1002/jcla.24434 PMC 바로가기 [Article Type] Meta-Analysis
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trialsCOVID-19로 입원한 환자를 위한 Janus kinase inhibitors: 무작위 대조 시험의 메타 분석Meta-Analysis Published on 2022-05-012022-09-11 Journal: Expert review of anti-infective therapy [Category] [DOI] 10.1080/14787210.2022.2004120 PMC 바로가기 [Article Type] Meta-Analysis
Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure중증 호흡부전이 있는 COVID-19 환자의 구조 치료로서 흡입형 DNase, 바리시티닙 및 토실리주맙의 병용 투여Article Published on 2022-05-012022-09-12 Journal: Clinical immunology (Orlando, Fla.) [Category] [DOI] 10.1016/j.clim.2022.109016 PMC 바로가기 [Article Type] Article